|
Equity risk premium - which Risk free to use?
|
|
2
|
870
|
June 3, 2016
|
|
Fama-French model
|
|
8
|
1392
|
June 3, 2016
|
|
Equity risk premium - which Risk free to use?
|
|
1
|
909
|
June 3, 2016
|
|
Equity - SMGI
|
|
7
|
932
|
June 2, 2016
|
|
EPS normalization (schweser mock #6 AM Q.32)
|
|
1
|
1027
|
June 1, 2016
|
|
Enterprise Multiples
|
|
1
|
911
|
June 1, 2016
|
|
Why is non-controlling interest excluded from BVPS?
|
|
3
|
1220
|
May 31, 2016
|
|
Equity - Metev Q2
|
|
6
|
910
|
May 30, 2016
|
|
Equity growth rate
|
|
2
|
1279
|
May 30, 2016
|
|
Eoc- q1 effect of increase in int expense on FCFF (Reading 35 FCF valuation)
|
|
0
|
854
|
May 30, 2016
|
|
Equity Risk Premium vs Market Risk Premiun
|
|
3
|
1571
|
May 30, 2016
|
|
Metev Equity Question #4 - Enterprise Value Adjustments
|
|
1
|
917
|
May 29, 2016
|
|
FCFF for Leveraged Firms?
|
|
2
|
1114
|
May 29, 2016
|
|
When to use NCC and Dep when deriving FCFF and FCFE
|
|
8
|
2027
|
May 29, 2016
|
|
Equity Risk Premium: Ibbotson Chen
|
|
3
|
1431
|
May 29, 2016
|
|
Investment Value vs Intrinsic Value
|
|
1
|
1286
|
May 29, 2016
|
|
Residual Income discrpency
|
|
0
|
807
|
May 29, 2016
|
|
Working Capital: Interest Payable and Notes Payable
|
|
1
|
914
|
May 29, 2016
|
|
FCFF & Revenue Growth
|
|
0
|
916
|
May 28, 2016
|
|
idosyncratic risk affect on market risk
|
|
1
|
968
|
May 26, 2016
|
|
Depreciation Line Item (FCFE & FCFF)
|
|
1
|
902
|
May 26, 2016
|
|
NI includes preferred dividend?
|
|
14
|
1262
|
May 25, 2016
|
|
Equity topic test - Metev
|
|
4
|
972
|
May 25, 2016
|
|
Private Company Valuation
|
|
1
|
901
|
May 23, 2016
|
|
Justified P/B Ratio Formula
|
|
3
|
1877
|
May 23, 2016
|
|
Equity value
|
|
1
|
873
|
May 22, 2016
|
|
FCFE - Net Borrowing - Preferred Stock
|
|
6
|
1251
|
May 19, 2016
|
|
Required Rate of Return for different countries - Equity topic test, Pacific Wind case
|
|
2
|
1039
|
May 19, 2016
|
|
Equity Risk Premium
|
|
6
|
1207
|
May 19, 2016
|
|
Persistance Factor
|
|
7
|
1029
|
May 18, 2016
|